tert-Butyl 4-oxopiperidine-1-carboxylate → 1-Boc-4-Methylenepiperidine
Reaction equation
[CH2:1]([Li])[CH2:2][CH2:3][CH3:4].O=C1CC[N:10]([C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[CH2:9][CH2:8]1>[Br-].C[P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.C1COCC1.CCCCCC>[CH2:4]=[C:3]1[CH2:8][CH2:9][N:10]([C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])[CH2:1][CH2:2]1Participants
Procedure
To a solution of methyl triphenylphosphonium bromide (2.69 g, 7.5 mmol) in THF (20 mL) was n-butyllithium (1.8 M; 4.2 mL, 7.5 mmol) in hexane slowly added at −78° C. The mixture was stirred for 1 h. After this time, a solution of tert-butyl 4-oxopiperidine-1-carboxylate (1 g, 5.0 mmol) in THF (10 mL) was added dropwise to the mixture. The resultant mixture was stirred at room temperature overnight. The reaction mixture was quenched with water and extracted with isohexane (×3). The combined isohexane layers were evaporated and filtrated through a silica-plug. The crude product was purified using flash chromatography with DCM as eluent yielding 0.58 g (59%) of the title compound. HPLC purity 91%, RT=2.47 min (System A; 10-97% MeCN over 3 min); 86%, RT=2.43 min (System B; 10-97% MeCN over 3 min). 1H NMR (400 MHz, CDCl3) δ ppm 1.46 (s, 9H) 2.12-2.22 (m, 4H) 3.35-3.46 (m, 4H) 4.73 (s, 2H). MS (ESI+) for C11H19NO2 m/z 142 (M-C4H8)+. *Previously reported in J. Med. Chem. 2002, 45, 3143-3160.
Workup
- additionslowly added at −78° C
- customThe reaction mixture was quenched with water
- extractionextracted with isohexane (×3)
- customThe combined isohexane layers were evaporated
- filtrationfiltrated through a silica-plug
- customThe crude product was purified
Sources & evidence
- ORD record
- ord-c2b559c23a434f7aab74bd168abe9713
- Source dataset
- uspto-grants-2010_10
- Patent number
- US07820675B2
Reaction notes
Loading…